Antibody News and Research

RSS
An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Further Reading

Study evaluates the presence of the SARS-CoV-2 spike protein in urine samples collected during the COVID-19 pandemic

Study evaluates the presence of the SARS-CoV-2 spike protein in urine samples collected during the COVID-19 pandemic

Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

Developing and manufacturing custom recombinant antibodies for R&D

Developing and manufacturing custom recombinant antibodies for R&D

How comorbidities impact antibody response to COVID vaccination

How comorbidities impact antibody response to COVID vaccination

Study says duplilumab reduces mortality from COVID-19

Study says duplilumab reduces mortality from COVID-19

Swedish HCW study shows COVID booster shots have limited effect on Omicron

Swedish HCW study shows COVID booster shots have limited effect on Omicron

Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

SARS-CoV-2 ORF8 interferes with antibody-dependent cellular cytotoxicity

SARS-CoV-2 ORF8 interferes with antibody-dependent cellular cytotoxicity

Pre-existing memory B cell dynamics during SARS-CoV-2 Omicron breakthrough infection

Pre-existing memory B cell dynamics during SARS-CoV-2 Omicron breakthrough infection

Investigating extensive SARS-CoV-2 neutralizing immunoglobulins from COVID-19 recovered subjects

Investigating extensive SARS-CoV-2 neutralizing immunoglobulins from COVID-19 recovered subjects

Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages

Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages

Recombinant fragment of the lectin-binding region of Gal-3BP stimulates the expression of IL-6 in SARS-CoV-2 sensitive cells

Recombinant fragment of the lectin-binding region of Gal-3BP stimulates the expression of IL-6 in SARS-CoV-2 sensitive cells

Prior COVID vaccination induces a more robust antibody response to Omicron

Prior COVID vaccination induces a more robust antibody response to Omicron

Study on the efficacy of a BNT162b2 booster dose in the elderly

Study on the efficacy of a BNT162b2 booster dose in the elderly

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

BNT162b2 booster vaccine provides equal protection against BA.1 and BA.2

BNT162b2 booster vaccine provides equal protection against BA.1 and BA.2

Key protein could be a novel target for treatment of patients with B cell signaling deficiencies

Key protein could be a novel target for treatment of patients with B cell signaling deficiencies

Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

Study shows SARS-CoV-2 antibodies persist for one-year post-infection with protection from other variants

Study shows SARS-CoV-2 antibodies persist for one-year post-infection with protection from other variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.